+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cloud-Based Drug Discovery Platforms - Global Market Trajectory & Analytics

  • ID: 5309385
  • Report
  • April 2021
  • Region: Global
  • 111 pages
  • Global Industry Analysts, Inc
1 of 2
Global Cloud-Based Drug Discovery Platforms Market to Reach $4.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Cloud-Based Drug Discovery Platforms estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$4.6 Billion by 2027, growing at a CAGR of 12.5% over the analysis period 2020-2027. Pharmaceutical Vendors, one of the segments analyzed in the report, is projected to record a 12.9% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biotech Vendors segment is readjusted to a revised 13.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $593.9 Million, While China is Forecast to Grow at 12.1% CAGR

The Cloud-Based Drug Discovery Platforms market in the U.S. is estimated at US$593.9 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$802.8 Million by the year 2027 trailing a CAGR of 12.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.1% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Contract Research Organizations Segment to Record 9.8% CAGR

In the global Contract Research Organizations segment, USA, Canada, Japan, China and Europe will drive the 9.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$240.4 Million in the year 2020 will reach a projected size of US$457.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$544.4 Million by the year 2027.

Select Competitors (Total 41 Featured):
  • Accenture PLC
  • Acelot, Inc.
  • Cloud Pharmaceuticals, Inc.
  • Dassault Systemes
  • IBM Corporation
  • SAS Institute, Inc.
  • Tata Consultancy Services Ltd.
  • WuXi AppTec
Note: Product cover images may vary from those shown
2 of 2
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Cloud-Based Drug Discovery Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Cloud-Based Drug Discovery Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Pharmaceutical Vendors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Pharmaceutical Vendors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Biotech Vendors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Biotech Vendors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • Table 11: USA Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 12: USA 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 13: Canada Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: Canada 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 15: Japan Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 16: Japan 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 17: China Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 18: China 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 19: Europe Current & Future Analysis for Cloud-Based Drug Discovery Platforms by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: Europe 7-Year Perspective for Cloud-Based Drug Discovery Platforms by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 21: Europe Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: Europe 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 23: France Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: France 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 25: Germany Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Germany 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 27: Italy Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: Italy 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 29: UK Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: UK 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 31: Rest of Europe Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Rest of Europe 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 33: Asia-Pacific Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Asia-Pacific 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
  • Table 35: Rest of World Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: Rest of World 7-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown
Adroll
adroll